{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:43:32Z","timestamp":1791607412744,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/nrc3500","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T06:14:36Z","timestamp":1366784076000},"page":"328-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":360,"title":["Beyond TGF\u03b2: roles of other TGF\u03b2 superfamily members in cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Lalage M.","family":"Wakefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"BFnrc3500_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc2467","volume":"8","author":"JC Hardwick","year":"2008","unstructured":"Hardwick, J. C., Kodach, L. L., Offerhaus, G. J. & van den Brink, G. R. Bone morphogenetic protein signalling in colorectal cancer. Nature Rev. Cancer 8, 806\u2013812 (2008).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc3500_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.stem.2012.11.001","volume":"11","author":"N Oshimori","year":"2012","unstructured":"Oshimori, N. & Fuchs, E. The Harmonies played by TGF-\u03b2 in stem cell biology. Cell Stem Cell 11, 751\u2013764 (2012).","journal-title":"Cell Stem Cell"},{"key":"BFnrc3500_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","volume":"16","author":"MY Wu","year":"2009","unstructured":"Wu, M. Y. & Hill, C. S. TGF-\u03b2 superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329\u2013343 (2009).","journal-title":"Dev. Cell"},{"key":"BFnrc3500_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2148-9-28","volume":"9","author":"L Huminiecki","year":"2009","unstructured":"Huminiecki, L. et al. Emergence, development and diversification of the TGF-\u03b2 signalling pathway within the animal kingdom. BMC Evol. Biol. 9, 28 (2009).","journal-title":"BMC Evol. Biol."},{"key":"BFnrc3500_CR5","doi-asserted-by":"publisher","first-page":"e24152","DOI":"10.1371\/journal.pone.0024152","volume":"6","author":"K Pang","year":"2011","unstructured":"Pang, K., Ryan, J. F., Baxevanis, A. D. & Martindale, M. Q. Evolution of the TGF-\u03b2 signaling pathway and its potential role in the ctenophore, Mnemiopsis leidyi. PLoS ONE 6, e24152 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrc3500_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1083\/jcb.144.1.139","volume":"144","author":"DB Constam","year":"1999","unstructured":"Constam, D. B. & Robertson, E. J. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 144, 139\u2013149 (1999).","journal-title":"J. Cell Biol."},{"key":"BFnrc3500_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1101\/gad.14.9.1146","volume":"14","author":"DB Constam","year":"2000","unstructured":"Constam, D. B. & Robertson, E. J. SPC4\/PACE4 regulates a TGF\u03b2 signaling network during axis formation. Genes Dev. 14, 1146\u20131155 (2000).","journal-title":"Genes Dev."},{"key":"BFnrc3500_CR8","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.febslet.2012.02.043","volume":"586","author":"TD Mueller","year":"2012","unstructured":"Mueller, T. D. & Nickel, J. Promiscuity and specificity in BMP receptor activation. FEBS Lett. 586, 1846\u20131859 (2012).","journal-title":"FEBS Lett."},{"key":"BFnrc3500_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi, Y. & Massague, J. Mechanisms of TGF-\u03b2 signaling from cell membrane to the nucleus. Cell 113, 685\u2013700 (2003).","journal-title":"Cell"},{"key":"BFnrc3500_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tcb.2009.05.008","volume":"19","author":"JS Kang","year":"2009","unstructured":"Kang, J. S., Liu, C. & Derynck, R. New regulatory mechanisms of TGF-\u03b2 receptor function. Trends Cell Biol. 19, 385\u2013394 (2009).","journal-title":"Trends Cell Biol."},{"key":"BFnrc3500_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans, M. J. et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF\u03b2\/ALK5 signaling. Mol. Cell 12, 817\u2013828 (2003).","journal-title":"Mol. Cell"},{"key":"BFnrc3500_CR12","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1128\/MCB.01192-08","volume":"28","author":"AC Daly","year":"2008","unstructured":"Daly, A. C., Randall, R. A. & Hill, C. S. Transforming growth factor \u03b2-induced Smad1\/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28, 6889\u20136902 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc3500_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/emboj.2008.266","volume":"28","author":"IM Liu","year":"2009","unstructured":"Liu, I. M. et al. TGF\u03b2-stimulated Smad1\/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGF\u03b2 switch. EMBO J. 28, 88\u201398 (2009).","journal-title":"EMBO J."},{"key":"BFnrc3500_CR14","doi-asserted-by":"publisher","first-page":"9755","DOI":"10.1074\/jbc.M809223200","volume":"284","author":"KH Wrighton","year":"2009","unstructured":"Wrighton, K. H., Lin, X., Yu, P. B. & Feng, X. H. Transforming growth factor \u03b2 can stimulate Smad1 phosphorylation independently of bone morphogenic protein receptors. J. Biol. Chem. 284, 9755\u20139763 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrc3500_CR15","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1242\/dev.01248","volume":"131","author":"GC Chu","year":"2004","unstructured":"Chu, G. C., Dunn, N. R., Anderson, D. C., Oxburgh, L. & Robertson, E. J. Differential requirements for Smad4 in TGF\u03b2-dependent patterning of the early mouse embryo. Development 131, 3501\u20133512 (2004).","journal-title":"Development"},{"key":"BFnrc3500_CR16","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1128\/MCB.25.18.8108-8125.2005","volume":"25","author":"L Levy","year":"2005","unstructured":"Levy, L. & Hill, C. S. Smad4 dependency defines two classes of transforming growth factor \u03b2 (TGF-\u03b2) target genes and distinguishes TGF-\u03b2-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol. Cell. Biol. 25, 8108\u20138125 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc3500_CR17","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1128\/MCB.00231-12","volume":"32","author":"E Gronroos","year":"2012","unstructured":"Gronroos, E. et al. Transforming growth factor \u03b2 inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1\/5-Smad3 complexes. Mol. Cell. Biol. 32, 2904\u20132916 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc3500_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biocel.2007.09.006","volume":"40","author":"S Ross","year":"2008","unstructured":"Ross, S. & Hill, C. S. How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40, 383\u2013408 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnrc3500_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/383691a0","volume":"383","author":"X Chen","year":"1996","unstructured":"Chen, X., Rubock, M. J. & Whitman, M. A transcriptional partner for MAD proteins in TGF-\u03b2 signalling. Nature 383, 691\u2013696 (1996).","journal-title":"Nature"},{"key":"BFnrc3500_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.febslet.2012.02.001","volume":"586","author":"DL Bruce","year":"2012","unstructured":"Bruce, D. L. & Sapkota, G. P. Phosphatases in SMAD regulation. FEBS Lett. 586, 1897\u20131905 (2012).","journal-title":"FEBS Lett."},{"key":"BFnrc3500_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/nrm2297","volume":"8","author":"B Schmierer","year":"2007","unstructured":"Schmierer, B. & Hill, C. S. TGF\u03b2-SMAD signal transduction: molecular specificity and functional flexibility. Nature Rev. Mol. Cell Biol. 8, 970\u2013982 (2007).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc3500_CR22","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.febslet.2012.02.035","volume":"586","author":"MC Ramel","year":"2012","unstructured":"Ramel, M. C. & Hill, C. S. Spatial regulation of BMP activity. FEBS Lett. 586, 1929\u20131941 (2012).","journal-title":"FEBS Lett."},{"key":"BFnrc3500_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague, J. TGF\u03b2 signalling in context. Nature Rev. Mol. Cell Biol. 13, 616\u2013630 (2012).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc3500_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stem.2012.01.014","volume":"10","author":"AM Singh","year":"2012","unstructured":"Singh, A. M. et al. Signaling network crosstalk in human pluripotent cells: a Smad2\/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 10, 312\u2013326 (2012). This paper explains the underlying mechanism that dictates whether activin signalling in HESCs induces pluripotency or differentiation.","journal-title":"Cell Stem Cell"},{"key":"BFnrc3500_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ydbio.2008.09.006","volume":"325","author":"AJ Levine","year":"2009","unstructured":"Levine, A. J., Levine, Z. J. & Brivanlou, A. H. GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses. Dev. Biol. 325, 43\u201348 (2009).","journal-title":"Dev. Biol."},{"key":"BFnrc3500_CR26","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1242\/dev.124.22.4467","volume":"124","author":"AF Candia","year":"1997","unstructured":"Candia, A. F. et al. Cellular interpretation of multiple TGF-\u03b2 signals: intracellular antagonism between activin\/BVg1 and BMP-2\/4 signaling mediated by Smads. Development 124, 4467\u20134480 (1997).","journal-title":"Development"},{"key":"BFnrc3500_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ceb.2007.02.015","volume":"19","author":"S Itoh","year":"2007","unstructured":"Itoh, S. & ten Dijke, P. Negative regulation of TGF-\u03b2 receptor\/Smad signal transduction. Curr. Opin. Cell Biol. 19, 176\u2013184 (2007).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrc3500_CR28","doi-asserted-by":"publisher","first-page":"19747","DOI":"10.1074\/jbc.M109.077347","volume":"285","author":"KE Galvin","year":"2010","unstructured":"Galvin, K. E., Travis, E. D., Yee, D., Magnuson, T. & Vivian, J. L. Nodal signaling regulates the bone morphogenic protein pluripotency pathway in mouse embryonic stem cells. J. Biol. Chem. 285, 19747\u201319756 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrc3500_CR29","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1242\/dev.02413","volume":"133","author":"D Mesnard","year":"2006","unstructured":"Mesnard, D., Guzman-Ayala, M. & Constam, D. B. Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development 133, 2497\u20132505 (2006).","journal-title":"Development"},{"key":"BFnrc3500_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrm2618","volume":"10","author":"SJ Arnold","year":"2009","unstructured":"Arnold, S. J. & Robertson, E. J. Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nature Rev. Mol. Cell Biol. 10, 91\u2013103 (2009).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc3500_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1146\/annurev.cellbio.19.041603.094522","volume":"19","author":"AF Schier","year":"2003","unstructured":"Schier, A. F. Nodal signaling in vertebrate development. Annu. Rev. Cell Dev. Biol. 19, 589\u2013621 (2003).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrc3500_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2353\/ajpath.2010.100102","volume":"177","author":"C Bianco","year":"2010","unstructured":"Bianco, C. et al. Role of Cripto-1 in stem cell maintenance and malignant progression. Am. J. Pathol. 177, 532\u2013540 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrc3500_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature09228","volume":"465","author":"MF Pera","year":"2010","unstructured":"Pera, M. F. & Tam, P. P. Extrinsic regulation of pluripotent stem cells. Nature 465, 713\u2013720 (2010).","journal-title":"Nature"},{"key":"BFnrc3500_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1242\/dev.033951","volume":"136","author":"L Vallier","year":"2009","unstructured":"Vallier, L. et al. Activin\/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136, 1339\u20131349 (2009).","journal-title":"Development"},{"key":"BFnrc3500_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jb\/mvp148","volume":"147","author":"K Miyazono","year":"2010","unstructured":"Miyazono, K., Kamiya, Y. & Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J. Biochem. 147, 35\u201351 (2010).","journal-title":"J. Biochem."},{"key":"BFnrc3500_CR36","first-page":"mr1","volume":"3","author":"DO Wagner","year":"2010","unstructured":"Wagner, D. O. et al. BMPs: from bone to body morphogenetic proteins. Sci. Signal. 3, mr1 (2010).","journal-title":"Sci. Signal."},{"key":"BFnrc3500_CR37","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1158\/0008-5472.CAN-11-3419","volume":"72","author":"L Strizzi","year":"2012","unstructured":"Strizzi, L., Hardy, K. M., Kirschmann, D. A., Ahrlund-Richter, L. & Hendrix, M. J. Nodal expression and detection in cancer: experience and challenges. Cancer Res. 72, 1915\u20131920 (2012).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283\u2013296 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrc3500_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm2636","volume":"10","author":"C Blanpain","year":"2009","unstructured":"Blanpain, C. & Fuchs, E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nature Rev. Mol. Cell Biol. 10, 207\u2013217 (2009).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnrc3500_CR40","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/dneu.22022","volume":"72","author":"AM Bond","year":"2012","unstructured":"Bond, A. M., Bhalala, O. G. & Kessler, J. A. The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation. Dev. Neurobiol. 72, 1068\u20131084 (2012).","journal-title":"Dev. Neurobiol."},{"key":"BFnrc3500_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ng1430","volume":"36","author":"XC He","year":"2004","unstructured":"He, X. C. et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-\u03b2-catenin signaling. Nature Genet. 36, 1117\u20131121 (2004). This paper demonstrates that conditional inactivation of ALK3 generates a mouse model of JPS and shows important antagonistic actions of BMP and WNT signalling on stem cell self-renewal.","journal-title":"Nature Genet."},{"key":"BFnrc3500_CR42","doi-asserted-by":"publisher","first-page":"15418","DOI":"10.1073\/pnas.0707210104","volume":"104","author":"C Kosinski","year":"2007","unstructured":"Kosinski, C. et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl Acad. Sci. USA 104, 15418\u201315423 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrg1178","volume":"4","author":"KA Waite","year":"2003","unstructured":"Waite, K. A. & Eng, C. From developmental disorder to heritable cancer: it's all in the BMP\/TGF-\u03b2 family. Nature Rev. Genet. 4, 763\u2013773 (2003).","journal-title":"Nature Rev. Genet."},{"key":"BFnrc3500_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.2263","volume":"44","author":"E Jaeger","year":"2012","unstructured":"Jaeger, E. et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nature Genet. 44, 699\u2013703 (2012). This paper demonstrates that a genetic lesion leading to overexpression of the BMP antagonist gremlin 1 underlies hereditary mixed polyposis syndrome.","journal-title":"Nature Genet."},{"key":"BFnrc3500_CR45","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1093587","volume":"303","author":"AP Haramis","year":"2004","unstructured":"Haramis, A. P. et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303, 1684\u20131686 (2004).","journal-title":"Science"},{"key":"BFnrc3500_CR46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/dvdy.22009","volume":"239","author":"N Itasaki","year":"2010","unstructured":"Itasaki, N. & Hoppler, S. Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev. Dyn. 239, 16\u201333 (2010).","journal-title":"Dev. Dyn."},{"key":"BFnrc3500_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1053\/j.gastro.2007.06.066","volume":"133","author":"BA Auclair","year":"2007","unstructured":"Auclair, B. A., Benoit, Y. D., Rivard, N., Mishina, Y. & Perreault, N. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology 133, 887\u2013896 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrc3500_CR48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","volume":"145","author":"C Scheel","year":"2011","unstructured":"Scheel, C. et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926\u2013940 (2011).","journal-title":"Cell"},{"key":"BFnrc3500_CR49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0959-437X(02)00329-5","volume":"12","author":"DM Panchision","year":"2002","unstructured":"Panchision, D. M. & McKay, R. D. The control of neural stem cells by morphogenic signals. Curr. Opin. Genet. Dev. 12, 478\u2013487 (2002).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnrc3500_CR50","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761\u2013765 (2006).","journal-title":"Nature"},{"key":"BFnrc3500_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","volume":"13","author":"J Lee","year":"2008","unstructured":"Lee, J. et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69\u201380 (2008). This paper shows that ALK6 is epigenetically silenced in some human glioblastomas, causing reversion to an early embryonic BMP signalling pattern and the loss of inhibitory effects on the CSC population.","journal-title":"Cancer Cell"},{"key":"BFnrc3500_CR52","doi-asserted-by":"publisher","first-page":"14842","DOI":"10.1073\/pnas.0606857103","volume":"103","author":"JB Sneddon","year":"2006","unstructured":"Sneddon, J. B. et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl Acad. Sci. USA 103, 14842\u201314847 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR53","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/onc.2011.400","volume":"31","author":"JT Buijs","year":"2012","unstructured":"Buijs, J. T. et al. The BMP2\/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation. Oncogene 31, 2164\u20132174 (2012).","journal-title":"Oncogene"},{"key":"BFnrc3500_CR54","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1103441108","volume":"108","author":"G Upadhyay","year":"2011","unstructured":"Upadhyay, G. et al. Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-\u03b2 signaling. Proc. Natl Acad. Sci. USA 108, 7820\u20137825 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR55","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1158\/0008-5472.CAN-12-1013","volume":"72","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. Cancer Res. 72, 4276\u20134285 (2012).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccr.2012.10.007","volume":"22","author":"TA Gruber","year":"2012","unstructured":"Gruber, T. A. et al. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22, 683\u2013697 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrc3500_CR57","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1172\/JCI45273","volume":"121","author":"K McLean","year":"2011","unstructured":"McLean, K. et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J. Clin. Invest. 121, 3206\u20133219 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrc3500_CR58","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biocel.2012.12.021","volume":"45","author":"DF Quail","year":"2013","unstructured":"Quail, D. F., Siegers, G. M., Jewer, M. & Postovit, L. M. Nodal signalling in embryogenesis and tumourigenesis. Int. J. Biochem. Cell Biol. 45, 885\u2013898 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnrc3500_CR59","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nm1448","volume":"12","author":"JM Topczewska","year":"2006","unstructured":"Topczewska, J. M. et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Med. 12, 925\u2013932 (2006). This was the first demonstration that NODAL is secreted by tumour cells, with the level of NODAL correlating with tumour aggressiveness.","journal-title":"Nature Med."},{"key":"BFnrc3500_CR60","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/pros.21335","volume":"71","author":"MG Lawrence","year":"2011","unstructured":"Lawrence, M. G. et al. Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells. Prostate 71, 1198\u20131209 (2011).","journal-title":"Prostate"},{"key":"BFnrc3500_CR61","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/bcr3185","volume":"14","author":"L Strizzi","year":"2011","unstructured":"Strizzi, L. et al. Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer. Breast Cancer Res. 14, R75 (2011).","journal-title":"Breast Cancer Res."},{"key":"BFnrc3500_CR62","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1242\/dev.083006","volume":"139","author":"CM Spiller","year":"2012","unstructured":"Spiller, C. M. et al. Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development 139, 4123\u20134132 (2012).","journal-title":"Development"},{"key":"BFnrc3500_CR63","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1517\/13543776.2010.530659","volume":"20","author":"C Bianco","year":"2010","unstructured":"Bianco, C. & Salomon, D. S. Targeting the embryonic gene Cripto-1 in cancer and beyond. Expert Opin. Ther. Pat. 20, 1739\u20131749 (2010).","journal-title":"Expert Opin. Ther. Pat."},{"key":"BFnrc3500_CR64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2011.10.001","volume":"9","author":"E Lonardo","year":"2011","unstructured":"Lonardo, E. et al. Nodal\/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 9, 433\u2013446 (2011). This was the first demonstration that NODAL and activin signalling promotes self-renewal of CSCs.","journal-title":"Cell Stem Cell"},{"key":"BFnrc3500_CR65","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1073\/pnas.0800467105","volume":"105","author":"LM Postovit","year":"2008","unstructured":"Postovit, L. M. et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc. Natl Acad. Sci. USA 105, 4329\u20134334 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR66","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1158\/0008-5472.CAN-10-0705","volume":"70","author":"KM Hardy","year":"2010","unstructured":"Hardy, K. M. et al. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype. Cancer Res. 70, 10340\u201310350 (2010).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/epi.09.25","volume":"1","author":"FF Costa","year":"2009","unstructured":"Costa, F. F. et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 1, 387\u2013398 (2009).","journal-title":"Epigenomics"},{"key":"BFnrc3500_CR68","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","volume":"181","author":"RE Seftor","year":"2012","unstructured":"Seftor, R. E. et al. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am. J. Pathol. 181, 1115\u20131125 (2012).","journal-title":"Am. J. Pathol."},{"key":"BFnrc3500_CR69","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1158\/0008-5472.CAN-11-3951","volume":"72","author":"DF Quail","year":"2012","unstructured":"Quail, D. F. et al. Embryonic protein nodal promotes breast cancer vascularization. Cancer Res. 72, 3851\u20133863 (2012).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR70","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.4161\/cc.19679","volume":"11","author":"E Lonardo","year":"2012","unstructured":"Lonardo, E., Frias-Aldeguer, J., Hermann, P. C. & Heeschen, C. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness. Cell Cycle 11, 1282\u20131290 (2012).","journal-title":"Cell Cycle"},{"key":"BFnrc3500_CR71","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Ocana","year":"2012","unstructured":"Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer prrx1. Cancer Cell 22, 709\u2013724 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrc3500_CR72","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ccr.2012.09.022","volume":"22","author":"JH Tsai","year":"2012","unstructured":"Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725\u2013736 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrc3500_CR73","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc3265","volume":"12","author":"T Brabletz","year":"2012","unstructured":"Brabletz, T. To differentiate or not--routes towards metastasis. Nature Rev. Cancer 12, 425\u2013436 (2012).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc3500_CR74","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Rev. Cancer 9, 265\u2013273 (2009).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc3500_CR75","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2353\/ajpath.2007.070168","volume":"171","author":"JT Buijs","year":"2007","unstructured":"Buijs, J. T. et al. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am. J. Pathol. 171, 1047\u20131057 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrc3500_CR76","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature09677","volume":"470","author":"Z Ding","year":"2011","unstructured":"Ding, Z. et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470, 269\u2013273 (2011).","journal-title":"Nature"},{"key":"BFnrc3500_CR77","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jcb.21509","volume":"102","author":"JM Bailey","year":"2007","unstructured":"Bailey, J. M., Singh, P. K. & Hollingsworth, M. A. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell Biochem. 102, 829\u2013839 (2007).","journal-title":"J. Cell Biochem."},{"key":"BFnrc3500_CR78","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","volume":"150","author":"H Gao","year":"2012","unstructured":"Gao, H. et al. The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell 150, 764\u2013779 (2012). This paper shows that tumour cells can upregulate BANG antagonists to overcome organ-specific BMP barriers to metastatic colonization.","journal-title":"Cell"},{"key":"BFnrc3500_CR79","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20110840","volume":"208","author":"A Kobayashi","year":"2011","unstructured":"Kobayashi, A. et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J. Exp. Med. 208, 2641\u20132655 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrc3500_CR80","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2010.04.015","volume":"7","author":"P Samavarchi-Tehrani","year":"2010","unstructured":"Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64\u201377 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFnrc3500_CR81","doi-asserted-by":"publisher","first-page":"21346","DOI":"10.1074\/jbc.M112.355834","volume":"287","author":"M Tarragona","year":"2012","unstructured":"Tarragona, M. et al. Identification of NOG as a specific breast cancer bone metastasis-supporting gene. J. Biol. Chem. 287, 21346\u201321355 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrc3500_CR82","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/onc.2008.232","volume":"27","author":"Y Katsuno","year":"2008","unstructured":"Katsuno, Y. et al. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene 27, 6322\u20136333 (2008).","journal-title":"Oncogene"},{"key":"BFnrc3500_CR83","doi-asserted-by":"publisher","first-page":"20037","DOI":"10.1074\/jbc.M112.353094","volume":"287","author":"H Nishimori","year":"2012","unstructured":"Nishimori, H., Ehata, S., Suzuki, H. I., Katsuno, Y. & Miyazono, K. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals. J. Biol. Chem. 287, 20037\u201320046 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrc3500_CR84","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1182\/blood-2011-01-330142","volume":"117","author":"SI Cunha","year":"2011","unstructured":"Cunha, S. I. & Pietras, K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 117, 6999\u20137006 (2011).","journal-title":"Blood"},{"key":"BFnrc3500_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1084\/jem.20091309","volume":"207","author":"SI Cunha","year":"2010","unstructured":"Cunha, S. I. et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J. Exp. Med. 207, 85\u2013100 (2010). This study implicated ALK1 ligands as key players in tumour angiogenesis.","journal-title":"J. Exp. Med."},{"key":"BFnrc3500_CR86","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-10-1451","volume":"71","author":"DD Hu-Lowe","year":"2011","unstructured":"Hu-Lowe, D. D. et al. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Res. 71, 1362\u20131373 (2011).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR87","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/17469872.4.1.67","volume":"4","author":"L Strizzi","year":"2009","unstructured":"Strizzi, L. et al. Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev. Dermatol. 4, 67\u201378 (2009).","journal-title":"Expert Rev. Dermatol."},{"key":"BFnrc3500_CR88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-12-385961-7.00013-5","volume":"85","author":"MP Hedger","year":"2011","unstructured":"Hedger, M. P., Winnall, W. R., Phillips, D. J. & de Kretser, D. M. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam. Horm. 85, 255\u2013297 (2011).","journal-title":"Vitam. Horm."},{"key":"BFnrc3500_CR89","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/ncomms1585","volume":"2","author":"M Antsiferova","year":"2011","unstructured":"Antsiferova, M. et al. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nature Commun. 2, 576 (2011).","journal-title":"Nature Commun."},{"key":"BFnrc3500_CR90","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","volume":"16","author":"P Roth","year":"2010","unstructured":"Roth, P. et al. GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin. Cancer Res. 16, 3851\u20133859 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc3500_CR91","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1158\/0008-5472.CAN-11-0188","volume":"72","author":"J Corre","year":"2012","unstructured":"Corre, J. et al. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma. Cancer Res. 72, 1395\u20131406 (2012).","journal-title":"Cancer Res."},{"key":"BFnrc3500_CR92","first-page":"2125","volume":"81","author":"K Harada","year":"1996","unstructured":"Harada, K. et al. Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J. Clin. Endocrinol. Metab. 81, 2125\u20132130 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrc3500_CR93","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet, S. et al. Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc. Natl Acad. Sci. USA 107, 5124\u20135129 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR94","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531\u2013543 (2010). This important preclinical study showed that neutralization of ACTRIIB ligands leads to dramatically prolonged survival in cancer-bearing mice by reversing adverse effects of BANGs on host tissues.","journal-title":"Cell"},{"key":"BFnrc3500_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1517\/13543784.2013.738666","volume":"22","author":"SZ Fields","year":"2013","unstructured":"Fields, S. Z. et al. Activin receptor antagonists for cancer-related anemia and bone disease. Expert Opin. Investig. Drugs 22, 87\u2013101 (2013).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrc3500_CR96","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1073\/pnas.0610477104","volume":"104","author":"A Pellagatti","year":"2007","unstructured":"Pellagatti, A. et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc. Natl Acad. Sci. USA 104, 11406\u201311411 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR97","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","volume":"91","author":"MM Matzuk","year":"1994","unstructured":"Matzuk, M. M. et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl Acad. Sci. USA 91, 8817\u20138821 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR98","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1. Nature Med. 13, 1333\u20131340 (2007).","journal-title":"Nature Med."},{"key":"BFnrc3500_CR99","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1126\/science.1069525","volume":"296","author":"TA Zimmers","year":"2002","unstructured":"Zimmers, T. A. et al. Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486\u20131488 (2002).","journal-title":"Science"},{"key":"BFnrc3500_CR100","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad, F. et al. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110, 1860\u20131867 (2007).","journal-title":"Cancer"},{"key":"BFnrc3500_CR101","doi-asserted-by":"publisher","first-page":"12207","DOI":"10.1073\/pnas.1204929109","volume":"109","author":"M Baud'huin","year":"2012","unstructured":"Baud'huin, M. et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. Proc. Natl Acad. Sci. USA 109, 12207\u201312212 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR102","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1073\/pnas.0711263105","volume":"105","author":"RS Pearsall","year":"2008","unstructured":"Pearsall, R. S. et al. A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc. Natl Acad. Sci. USA 105, 7082\u20137087 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc3500_CR103","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.cellsig.2011.06.019","volume":"23","author":"J Vogt","year":"2011","unstructured":"Vogt, J., Traynor, R. & Sapkota, G. P. The specificities of small molecule inhibitors of the TGF\u03b2 and BMP pathways. Cell. Signal. 23, 1831\u20131842 (2011).","journal-title":"Cell. Signal."},{"key":"BFnrc3500_CR104","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.02.031","volume":"180","author":"MC Rangel","year":"2012","unstructured":"Rangel, M. C. et al. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am. J. Pathol. 180, 2188\u20132200 (2012).","journal-title":"Am. J. Pathol."},{"key":"BFnrc3500_CR105","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst, R. J. & Hata, A. Targeting the TGF\u03b2 signalling pathway in disease. Nature Rev. Drug Discov. 11, 790\u2013811 (2012).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrc3500_CR106","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ctrv.2012.03.003","volume":"38","author":"MR Alison","year":"2012","unstructured":"Alison, M. R., Lin, W. R., Lim, S. M. & Nicholson, L. J. Cancer stem cells: in the line of fire. Cancer Treat. Rev. 38, 589\u2013598 (2012).","journal-title":"Cancer Treat. Rev."},{"key":"BFnrc3500_CR107","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2010.10.005","volume":"140","author":"Y Lombardo","year":"2011","unstructured":"Lombardo, Y. et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140, 297\u2013309 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrc3500_CR108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/gutjnl-2011-301113","volume":"62","author":"T Ivanova","year":"2013","unstructured":"Ivanova, T. et al. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer. Gut 62, 22\u201333 (2013).","journal-title":"Gut"},{"key":"BFnrc3500_CR109","first-page":"3929","volume":"125","author":"M Antsiferova","year":"2012","unstructured":"Antsiferova, M. & Werner, S. The bright and the dark sides of activin in wound healing and cancer. J. Cell Sci. 125, 3929\u20133937 (2012).","journal-title":"J. Cell Sci."},{"key":"BFnrc3500_CR110","first-page":"109","volume":"2","author":"B Weigelt","year":"2012","unstructured":"Weigelt, B. & Downward, J. Genomic determinants of PI3K pathway inhibitor response in Cancer. Front. Oncol. 2, 109 (2012).","journal-title":"Cancer. Front. Oncol."},{"key":"BFnrc3500_CR111","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/gut.2011.237495","volume":"60","author":"LL Kodach","year":"2011","unstructured":"Kodach, L. L. et al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut 60, 1544\u20131553 (2011).","journal-title":"Gut"},{"key":"BFnrc3500_CR112","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbrc.2005.10.024","volume":"338","author":"F Kugimiya","year":"2005","unstructured":"Kugimiya, F. et al. Mechanism of osteogenic induction by FK506 via BMP\/Smad pathways. Biochem. Biophys. Res. Commun. 338, 872\u2013879 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrc3500_CR113","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00240-002-0282-1","volume":"30","author":"HG van der Poel","year":"2003","unstructured":"van der Poel, H. G., Hanrahan, C., Zhong, H. & Simons, J. W. Rapamycin induces Smad activity in prostate cancer cell lines. Urol. Res. 30, 380\u2013386 (2003).","journal-title":"Urol. Res."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrc3500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc3500","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc3500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:37:29Z","timestamp":1715258249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc3500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":113,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFnrc3500"],"URL":"https:\/\/doi.org\/10.1038\/nrc3500","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]},"assertion":[{"value":"24 April 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}